PredxBio

Spatial Intelligence Summit: Shaping the Future of Drug Discovery & Development

Hosted by PredxBio

You’re Registered!

Thank you for securing your spot at the
Spatial Intelligence Summit: Shaping the Future of Drug Discovery & Development.

November 5, 2025

8:00 AM EST - 3:00PM EST

The Assembly, 5051 Centre Ave, Pittsburgh, PA 15213, USA

What’s Next?

Check your inbox — a confirmation email with event details is on the way.

Save the date — add the Summit to your calendar.
Outlook® Calendar | Google Calendar | iCal®

SHARE ON LINKEDIN — let people know you’re coming.

Plan your visit — watch for upcoming details on travel, lodging, and networking opportunities.

We can’t wait to welcome you to Pittsburgh for a day of science, collaboration, and discovery.

Featured Presenters

Arutha Kulasinghe, PhD

Scientific Director
Queensland Spatial Biology Centre

Tullia Bruno, PhD

Assistant Professor of Immunology University of Pittsburgh School of Medicine

Prasad S. Adusumilli, MD

Vice Chair for Translational Research
Memorial Sloan Kettering Cancer Center

Hoifung Poon, PhD

General Manager
Microsoft Research

Ven Raju

President & CEO
Innovation Works

Carlo Bifulco, MD

Chief Medical Officer
Providence Genomics

Laura Dillon, PhD

Senior Director, Partnership Strategy Lead
AstraZeneca

Samir Hanash, MD, PhD

Director and Distinguished Chair, Clinical Cancer Prevention
MD Anderson Cancer Center

Vipul Baxi, MS, MBA

Executive Director, Computational Imaging and Digital Biomarkers
AMGEN

Davide Bedognetti, MD, PhD

Executive Director, Translational Medicine
Kite Pharma - A Gilead Company

Amanda Poholek, PhD

Associate Professor of Immunology
University of Pittsburgh School of Medicine

Michael Surace, PhD

Director, Cancer Biomarker Development
AstraZeneca

William Mifsud, MD, PhD

Senior Director, Pathology
Kite Pharma - A Gilead Company

S. Chakra Chennubhotla, PhD

Chief of AI, COO, and
Co-Founder
PredxBio

Stanley Marks, MD

UPMC Hillman Cancer Center

D. Lansing Taylor, PhD

University of Pittsburgh

AGENDA – NOV 5, 2025

Time Session Presenters
8:00 – 8:25 Registration & Badge Pickup
8:30 – 8:40 Summit Kickoff

Dusty Majumdar, PhD (CEO, PredxBio) &

Stanley Marks (Chairman, UPMC Hillman Cancer Center)

8:40 – 9:05

Shaping the Future of Drug Discovery & Development

Dusty Majumdar, PhD (PredxBio)
9:05 – 9:30 Keynote Presentation Arutha Kulasinghe, PhD (University of Queensland)
9:30 – 9:50 Spotlight Session Tullia Bruno, PhD (University of Pittsburgh)
9:50 – 10:05 Coffee Break  Networking
10:05 – 10:35 Spotlight Session

Chakra Chennubhotla, PhD (PredxBio) &

Filippo Pullara, PhD (PredxBio)

10:35 – 10:55 Spotlight Session Hoifung Poon, PhD (Microsoft Research)
10:55 – 11:15 Spotlight Session Carlo Bifulco, MD (Providence Genomics)
11:15 – 11:45

Industry Leaders Roundtable:

Driving the Future of Drug Discovery

Moderator:

Laura Dillon, PhD (AstraZeneca)

Panelists:

Davide Bedognetti, MD, PhD (Kite Pharma – A Gilead Company)

Vipul Baxi, MS, MBA (Amgen)

Jill Stefanelli, PhD (Modella AI)

Michael Surace, PhD (AstraZeneca)

William Mifsud, MD (Kite Pharma – A Gilead Company)

11:45 – 12:30 Lunch Networking 
12:30 – 12:50 Fireside Chat

Dusty Majumdar, PhD (PredxBio) &

Brian McKelligon (Former CEO of Akoya Biosciences)

12:50 – 1:10 Spotlight Session Michael Surace, PhD (AstraZeneca)
1:10 – 1:30 Spotlight Session Sam Hanash, MD, PhD (MD Anderson Cancer Center)
1:30 – 1:45 Coffee Break Desserts & Networking
1:45 – 2:05 Spotlight Session Jill Stefanelli, PhD (Modella AI)
2:05 – 2:25 Spotlight Session Prasad Adusumalli, MD (Memorial Sloan Kettering Cancer Center)
2:25 – 2:50

Fireside Chat:

Market Dynamics and Investment Climate

Ven Raju (Innovation Works),

Brianna McDonald (NW Angel Fund), 

Dave Edwards (WD Investments), &

Laura Dillon, PhD (AstraZeneca), with

Dusty Majumdar, PhD (PredxBio)

2:50 – 3:10 Spotlight Session Amanda Poholek, PhD (University of Pittsburgh)
3:10 – 3:40

Looking Ahead:

Charting What’s Next

Arutha Kulasinghe, PhD (University of Queensland),

Hoifung Poon, PhD (Microsoft),

Brian McKelligon (Former CEO of Akoya Biosciences), &

Sam Hanash, MD, PhD (MD Anderson Cancer Center), with

Dusty Majumdar, PhD (PredxBio)

About PredxBio

PredxBio is a global leader in AI-powered spatial biology, transforming complex tissue imaging and multi-modal data into actionable insights. Our proprietary platform enables pharmaceutical companies and research institutions to accelerate drug discovery, optimize clinical trials, and predict patient outcomes with unprecedented precision. By revealing the network biology of cancer, we are setting new standards for biomarker discovery and personalized medicine.

Subscribe to our Newsletter

* indicates required

Registration

Join us for the Spatial Intelligence Summit. Complimentary and paid registration categories are listed below – hurry, early bird pricing ends on September 30.

We received your request! One of our team members will be in touch as soon as possible.

Submit your Resume

Download Whitepaper

Download Whitepaper

B. Dusty Majumdar, PhD

CHIEF EXECUTIVE OFFICER

B. Dusty Majumdar, PhD  is a seasoned leader in Precision Healthcare with more than 20 years of experience in building and successfully launching innovative technologies across oncology, multi-omics, Real-World Evidence (RWE). diagnostic imaging and liquid biopsy platforms leveraging some of the industry’s most advanced AI platforms, genomic and clinical simulations (digital twins), and emerging medical imaging technologies. Dr. Majumdar’s experience includes leading strategy and marketing as the Chief Marketing Officer (CMO) at IBM and multiple commercial and technical leadership roles at GE Healthcare, Exact Sciences and 3M. He has also led the commercial and strategic functions in a range of start-ups in the healthcare/biopharma space over the last few years.  Dr. Majumdar is a widely respected global leader in the healthcare industry and holds a Ph.D. from the University of Texas at Austin and a bachelor’s degree from the Indian Institute of Technology (IIT), Kharagpur.  He has authored several peer-reviewed scientific publications and holds multiple patents.

Joe Camaratta

Sr. VP Business Development

Joe Camaratta specializes in medical technology innovation and commercialization, taking products from concept to clinical adoption. He held executive positions for GE Healthcare and Siemens Healthcare and built businesses in medical imaging, cardiology, and oncology. He founded and led two early stage medical technology companies that apply artificial intelligence to improve clinical decision-making.

Joe holds a Master of Science degree in Computer Science from Rutgers University and a Bachelor of Science degree in Computer Science from Drexel University. He currently serves as an advisor to the Entreprenuerial Investing Program of the Crohn’s & Colitis Foundation, and the University Science Center QED Program focused on commercialization of academic innovations

Bruce Campbell, MS

VP Software Engineering

Bruce leads the software engineering and quality assurance teams at PredxBio. As the VP of Software Engineering, he is responsible for analytical infrastructure, product development and the commercialization of machine learning, image processing, and computational biology algorithms. Prior to joining PredxBio, Bruce was at IBM and Xylem in global Director of Data Science roles. He has over 20 years of experience in digital pathology algorithms and is highly motivated to deliver care through digital and computational pathology. He has multiple successful FDA 510k device applications, and multiple CLIA certified algorithms deployed in clinical practice.

Bruce holds a BS in Physics and MS in Applied Mathematics from the University of Rochester, an MS in Statistics from North Carolina State University, and is currently pursuing graduate mathematics studies at The Ohio State University. Bruce loves the outdoors. You can find him hiking and rock climbing in Appalachia.